Large Molecule Bioanalytical Testing Services Market

Large molecule bioanalytical testing services sales will expand through 2036, with clinical services holding 61.3% of the phase segment in 2026. The market was valued at USD 1.88 billion in 2025 and grows from USD 2.1 billion in 2026 to USD 6.4 billion by 2036, creating an incremental opportunity of USD 4.26 billion.